Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen for Prevention of Heterotopic Ossification After Elbow Trauma
NCT00586365Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naproxen in heterotopic ossification (HO), sponsored by Massachusetts General Hospital. Planned start Oct 2007; status: withdrawn.
02
Drugs
naproxen
03
Conditions
heterotopic ossification (HO)
Beyond the preview
Go deeper on NCT00586365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586365.